GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models
Author(s)
Hanson, Jesse E; Ma, Keran; Elstrott, Justin; Weber, Martin; Saillet, Sandrine; Khan, Abdullah S; Simms, Jeffrey; Liu, Benjamin; Kim, Thomas A; Yu, Gui-Qiu; Chen, Yelin; Wang, Tzu-Ming; Jiang, Zhiyu; Liederer, Bianca M; Deshmukh, Gauri; Solanoy, Hilda; Chan, Connie; Sellers, Benjamin D; Volgraf, Matthew; Schwarz, Jacob B; Hackos, David H; Weimer, Robby M; Sheng, Morgan; Gill, T Michael; Scearce-Levie, Kimberly; Palop, Jorge J; ... Show more Show less
DownloadPublished version (2.976Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Hanson et al. examine the therapeutic effects of enhancing GluN2A-subunit-containing NMDAR function in Dravet syndrome and Alzheimer's disease mice. GNE-0723 treatment reduces aberrant low-frequency oscillations and epileptiform discharges and improves cognitive functions in both disease models. GluN2A NMDAR enhancers may benefit brain disorders with network hypersynchrony and cognitive impairments.
Date issued
2020Department
Picower Institute for Learning and Memory; Massachusetts Institute of Technology. Department of Brain and Cognitive SciencesJournal
Cell Reports
Publisher
Elsevier BV